Avid Bioservices Inc (CDMO)

[cjgaddy]

AK, they don’t just assign you as “Senior-Author” of an ASCO poster. Has to be a reason this latest Sunrise Biomarker Study all of a sudden has a PerkinElmer “Technology Strategist” as its Senior Author. That’s the “main guy in charge of the study”.

ASCO’17: 6-3-17 1:15-4:45pm, Abstract #11603, Track: Tumor Biology
“Preliminary Correlative Analysis of PD-L1 Expression from the Sunrise Study” (poster board #303)
http://abstracts.asco.org/199/AbstView_199_190902.html
AUTHORS:
**Peregrine: Nikoletta Kallinteris (Lead Author), M.Tang, Joe Shan
**Robert W. Franz CC, Earle A. Chiles Res. Inst., Providence CC, Portland: Rachel E. Sanborn
**Vanderbilt Univ. MC, Nashville: Leora Horn
**UTSW-MC/Dallas: David Gerber
**Cedars-Sinai Outpatient CC, Los Angeles: Ronald B. Natale
**Precision Medicine, Frederick, MD: Tobias Guennel
**PerkinElmer, Inc., Hopkinton, MA: Amanda Clement, Clifford Hoyt (Senior Author)

- - - - - - - - - -MORE:
SENIOR AUTHOR: Clifford Hoyt (Oncology Fellow/PerkinElmer)
Note (Nov2016):
“Mr. Hoyt is a Technology Strategist in the area of oncology, helping to identify clinical opportunities that can be addressed through new technologies & capabilities. This includes forming collaborations & partnerships with academic & industrial institutions.”
http://www.sciencemag.org/custom-publishing/webinars/multiplexed-immunohistochemistry-illuminating-tumor-microenvironment

=========================
Known Sunrise Biomarkers thru 4-2017(AACR): B2GPI, Complement+IL10, IFN-y – see http://tinyurl.com/kq7cy5o
The progression of Authors thru the 1st 3 Sunrize Biomakers (ending with aACR’17)...

.
.